cytrx Announces Plan To Initiate A Phase 2 Clinical Trial With INNO-206 In ...Medical News Today (press release)Animal studies conducted by INNO-206 inventor Dr. Felix Kratz, Department of Medical Oncology, Clinical Research, at the Tumor Biology Center in Freiburg, ...and more »